Dabur India Limited, one of India's leading FMCG companies, has confirmed the appointment of Nitin Ghadiyar as Executive Director of its Consumer Healthcare Business. "Dabur India has identified OTC as one of the growth drivers for the company and Ghadiyar will lend his expertise in giving impetus to the growth of the business, given his vast experience in the FMCG and pharmaceutical industry," said Sunil Duggal, CEO, Dabur India.
Dabur's Consumer Healthcare business is the company's oldest business that includes OTC, branded ethical, and generic products, including classical prescription based Ayurvedic medicines that are derived from 'grantha-based' formulations.
With an experience of over 25 years, Ghadiyar has held several senior management positions, including those of Group Director, Parke Davis; Managing Director, Reckitt-Piramal; and President and Executive Director, Johnson & Johnson in his earlier assignments. In his last assignment he was the President and CEO of Morepen Laboratories.
A Masters in Management from Jamnalal Bajaj Institute, Ghadiyar is widely regarded as an expert in the Indian FMCG, pharmaceutical and healthcare business. He has an experience of building more than 20 national brands including Halls, Chiclet, Listerine, Benadryl, Gelusil, Saridon, Lacto Calamine and the Erythropoietin megabrand - Eprex- in his earlier stints with various companies.